MENU
+Compare
PBH
Stock ticker: NYSE
AS OF
Oct 17, 04:59 PM (EDT)
Price
$62.07
Change
+$0.26 (+0.42%)
Capitalization
3.04B

PBH Prestige Consumer Healthcare Forecast, Technical & Fundamental Analysis

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers... Show more

PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PBH with price predictions
Oct 16, 2025

PBH in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 10, 2025

PBH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where PBH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where PBH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PBH advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PBH as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PBH entered a downward trend on October 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.639) is normal, around the industry mean (17.684). P/E Ratio (14.509) is within average values for comparable stocks, (73.162). Projected Growth (PEG Ratio) (2.388) is also within normal values, averaging (2.099). PBH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.757) is also within normal values, averaging (46.659).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PBH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PBH is expected to report earnings to rise 2.03% to 96 cents per share on November 06

Prestige Consumer Healthcare PBH Stock Earnings Reports
Q3'25
Est.
$0.97
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.30
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.01
The last earnings report on August 07 showed earnings per share of 94 cents, missing the estimate of $1.00. With 87.67K shares outstanding, the current market capitalization sits at 3.04B.
A.I. Advisor
published General Information

General Information

a company which markets over-the-counter drugs, household cleaning and personal care products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
660 White Plains Road
Phone
+1 914 524-6800
Employees
560
Web
https://www.prestigebrands.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTCCX29.470.31
+1.06%
Gabelli Global Content & Connect C
TROIX15.860.09
+0.57%
T. Rowe Price Overseas Stock I
DINIX24.110.13
+0.54%
BNY Mellon International Stock Index I
PASRX21.47-0.09
-0.42%
Putnam Dynamic Asset Allocation Gr R
MJRFX24.03-0.19
-0.78%
BlackRock Mid-Cap Value K

PBH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+1.44%
PAHC - PBH
41%
Loosely correlated
-1.46%
PRGO - PBH
33%
Poorly correlated
+0.70%
AMRX - PBH
33%
Poorly correlated
+0.92%
IRWD - PBH
32%
Poorly correlated
-3.73%
ZTS - PBH
31%
Poorly correlated
+0.80%
More

Groups containing PBH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+1.44%
Pharmaceuticals: Generic
industry (220 stocks)
24%
Poorly correlated
-0.14%